Lubdub AI offers a handheld platform that combines ECG, cardiac biomarker testing, and portable echocardiography to deliver instant, comprehensive heart assessments. The device streams data to a cloud portal where remote clinicians can review and interpret results, enabling point‑of‑need screening and monitoring for primary care and mobile health settings.
Funding
Funding not disclosed
Founders
Product
Problem
Access to comprehensive cardiac diagnostics is limited by the need for multiple separate devices, specialized operators, and centralized facilities, which restricts timely screening and monitoring, especially in remote or underserved settings.
Solution
Lubdub AI delivers an integrated “heart health in a box” platform that combines electrocardiogram (ECG) acquisition, cardiac biomarker analysis, and portable echocardiography into a single handheld system. The device captures all three data streams instantly, applies advanced analytics to generate a personalized cardiac health fingerprint, and securely uploads results to a cloud portal where remote specialists can review and interpret the findings. This workflow enables point‑of‑need cardiac screening and continuous monitoring without requiring on‑site expertise, supporting early detection and personalized care across any location.
Target Audience
Primary customers are primary care clinics, community health centers, and mobile health providers that need comprehensive cardiac screening capabilities without dedicated cardiology infrastructure.
Features
- Combined ECG, biomarker assay, and ultrasound imaging hardware in a compact, portable unit
- Real‑time data acquisition and indexing with proprietary analytics algorithms for rapid risk assessment
- Cloud‑based results repository that allows specialists to review, annotate, and diagnose remotely
- Automated quality checks and standardized reporting to ensure consistency across operators
- Scalable architecture that supports integration with existing tele‑health platforms and electronic health records